Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis

Annals of Surgery

Volumn 253, Issue 3, 2011, Pages 566-571

  Conrad, Claudius ^a   Hüsemann, Yves ^b   Niess, Hanno ^c   Von Luettichau, Irene ^d   Huss, Ralf ^c   Bauer, Christian ^e   Jauch, Karl Walter ^c   Klein, Christoph A ^b   Bruns, Christiane ^c   Nelson, Peter J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; GANCICLOVIR; RED FLUORESCENT PROTEIN; THYMIDINE KINASE;

ADOPTIVE TRANSFER; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GENE THERAPY; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL DIVISION; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENETIC LINKAGE; HERPES SIMPLEX VIRUS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SUICIDE GENE; SUICIDE GENE THERAPY; TRANSGENE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM;

ADENOCARCINOMA; ANGIOPOIETIN-1; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENES, REPORTER; GENES, TRANSGENIC, SUICIDE; GENETIC ENGINEERING; MAMMARY NEOPLASMS, EXPERIMENTAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSGENES;

EID: 79951673153     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181fcb5d8     Document Type: Article

References (34)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182-1186
2. Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358(19):2039-2049 (Pubitemid 351656458)
3. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005;8(3): 211-226 (Pubitemid 41317592)
4. Yu JM, Jun ES, Bae YC, Jung JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008;17(3):463-473 (Pubitemid 351948199)
5. Matuskova M, Hlubinova K, Pastorakova A, et al. HSV-tk expressing mes-enchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett. 2010;290:58-67
6. Yang B, Wu X, Mao Y, et al. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Neurosurgery. 2009;65(3):610-624; discussion 624
7. Menon LG, Kelly K, Yang HW, et al. Human bone marrow-derived mesenchy-mal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells. 2009;27(9):2320-2330
8. Xiang J, Tang J, Song C, et al. Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy. 2009;11(5):516-526
9. Zischek C, Niess H, Ischenko I, et al. Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg. 2009;250:747-753
10. Moore KA, Lemischka IR. "Tie-ing" down the hematopoietic niche. Cell. 2004;118(2):139-140
11. Conrad C, Gupta R, Mohan H, et al. Genetically engineered stem cells for therapeutic gene delivery. Curr Gene Ther. 2007;7(4):249-260 (Pubitemid 47232957)
12. Mesa-Tejada R, Keydar I, Ramanarayanan M, et al. Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. Proc Natl Acad Sci USA. 1978;75(3):1529-1533 (Pubitemid 8301591)
13. Conrad C, Gottgens B, Kinston S, et al. GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line. Exp Hematol. 2002;30(8): 887-895 (Pubitemid 34838891)
14. - progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev. 2005;14(3):329-336 (Pubitemid 40885257)
15. Bruns CJ, Harbison MT, Kuniyasu H, et al. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia. 1999;1(1):50-62
16. Huss R, Heil M, Moosmann S, et al. Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL(+) multipotent adult progenitor cell clones from peripheral blood. J Vasc Res 2004;41(5): 422-431 (Pubitemid 39541253)
17. Khalil PN, Weiler V, Nelson PJ, et al. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology. 2007;132(3):944-954 (Pubitemid 46440862)
18. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149-161 (Pubitemid 38962572)
19. Hewett PW, Daft EL, Murray JC. Cloning and partial characterization of the human tie-2 receptor tyrosine kinase gene promoter. Biochem Biophys Res Commun. 1998;252(3):546-551 (Pubitemid 28556813)
20. Dube A, Thai S, Gaspar J, et al. Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ Res. 2001;88(2):237-244 (Pubitemid 32147314)
21. Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256(5063):1550-1552
22. Boggio K, Nicoletti G, Di Carlo E, et al. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med. 1998;188(3):589-596 (Pubitemid 28369147)
23. Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13(1):58-68 (Pubitemid 350309740)
24. Hillen F, Griffioen AW. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007;26(3-4):489-502 (Pubitemid 350115123)
25. Otsu K, Das S, Houser SD, et al. Concentration-dependent inhibition of angio-genesis by mesenchymal stem cells. Blood. 2009;113(18):4197-4205
26. Spring H, Schuler T, Arnold B, et al. Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA. 2005;102(50):18111- 18116 (Pubitemid 41798510)
27. Agarwal S, Nikolai B, Yamaguchi T, et al. Construction and use of retro-viral vectors encoding the toxic gene barnase. Mol Ther. 2006;14(4): 555-563 (Pubitemid 44296091)
28. Johannes L, Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 2005;12(18):1360-1368 (Pubitemid 43090385)
29. Dalba C, Klatzmann D, Logg CR, et al. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors. Curr Gene Ther. 2005;5(6):655-667 (Pubitemid 43009509)
30. Kaneda Y, Tabata Y. Non-viral vectors for cancer therapy. Cancer Sci. 2006;97(5):348-354
31. Ma J, Waxman DJ. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther. 2008;7(12):3670-3684
32. Mishra PJ, Mishra PJ, Humeniuk R, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008;68(11):4331-4339
33. Haniffa MA, Collin MP, Buckley CD, et al. Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica. 2009;94(2):258-263
34. Au P, Tam J, Fukumura D, et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood. 2008;111(9):4551-4558